Simris Group AB (PUBL) (STO:SIMRIS.B)
0.0972
-0.0033 (-3.28%)
May 21, 2026, 11:14 AM CET
Simris Group AB (PUBL) Revenue
Simris Group AB (PUBL) had revenue of 1.19M SEK in the quarter ending March 31, 2026, with 648.43% growth. This brings the company's revenue in the last twelve months to 2.65M, up 4.58% year-over-year. In the year 2025, Simris Group AB (PUBL) had annual revenue of 1.62M, down -44.12%.
Revenue (ttm)
2.65M
Revenue Growth
+4.58%
P/S Ratio
51.27
Revenue / Employee
529.20K
Employees
5
Market Cap
135.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.62M | -1.28M | -44.12% |
| Dec 31, 2024 | 2.89M | -1.46M | -33.62% |
| Dec 31, 2023 | 4.35M | 274.00K | 6.72% |
| Dec 31, 2022 | 4.08M | -2.29M | -35.92% |
| Dec 31, 2021 | 6.37M | 4.08M | 178.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 287.55M |
| IRLAB Therapeutics AB | 92.46M |
| Biovica International AB | 10.93M |
| Elicera Therapeutics AB | 10.64M |
| AcouSort AB | 10.43M |
| NextCell Pharma AB | 9.83M |
| OncoZenge AB | 2.78M |
| Alligator Bioscience AB | 520.00K |